Hepatitis B og C
1
Hepatitis B (2025)
Version 9.
Udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin og Dansk Selskab for Gastroenterologi og Hepatologi.
2
Screening før behandling med biologiske og målrettede syntetiske lægemidler (2023)
3
Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
4
Hepatitis C (2022)
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
5
Stikuheld og anden blodeksposition (2020)
Om håndtering og opfølgning for at minimere risiko for smitte med bl.a. HIV, HBV og HCV.
3
REACH-B Score for Hepatocellular Carcinoma (MDCalc)
https://www.mdcalc.com/calc/10031/reach-b-score-hepatocellular-carcinoma-hcc
4
Medicinrådets lægemiddelrekommandation for behandling af kronisk hepatitis C infektion
5
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
1
Hepatitis B virus infection and its determinants among pregnant women in Ethiopia: protocol for umbrella review of systematic review and meta-analysis 2025
BMJ Open
Tilføjet 4. marts 2026
2
Hepatitis B Vaccination Coverage and Vaccine‐Associated Immunity Among US‐Born Children and Adolescents: NHANES 2017–2020
Journal of Medical Virology
Tilføjet 23. februar 2026
3
Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
Journal of Medical Virology
Tilføjet 8. februar 2026
4
Construction of a depression risk prediction model for hepatitis B patients based on machine learning strategy
PLoS One Infectious Diseases
Tilføjet 5. februar 2026
5
Metabolic multimorbidity and liver fibrosis among people with hepatitis B in Senegal
International Journal of Infectious Diseases
Tilføjet 2. februar 2026
6
Hepatitis B virus (HBV) DNA is present as both cccDNA and integrated forms in kidney tissues of HBV surface antigen-negative patients with renal cell carcinoma
International Journal of Infectious Diseases
Tilføjet 28. januar 2026
7
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical in vivo models
Antimicrobial Agents And Chemotherapy
Tilføjet 27. januar 2026
8
Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study
PLoS One Infectious Diseases
Tilføjet 24. januar 2026
9
PEP-Hep: A cluster randomised controlled trial of a prison education programme to improve hepatitis B and C testing uptake and treatment initiation in Ghana - A study protocol
BMJ Open
Tilføjet 23. januar 2026
10
HepB-Boost: Implementation of free of charge healthcare worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya.
International Journal of Infectious Diseases
Tilføjet 23. januar 2026
11
Analysis of Hepatitis B Virus Integration Reveals New Insights of Oncogenic Mechanism in Dysplastic Liver Nodule
Journal of Medical Virology
Tilføjet 8. januar 2026
12
Anti-Interferon-α Antibodies and HBsAg Seroclearance during Peginterferon-α Therapy in Chronic Hepatitis B
International Journal of Infectious Diseases
Tilføjet 6. januar 2026
13
Preventing vertical transmission of hepatitis B in sub-Saharan Africa: protocol for a systematic review and meta-analysis on vaccination uptake and determinants among pregnant women
BMJ Open
Tilføjet 4. januar 2026
14
GLS4 Induces the Interferon Signaling Pathway During Hepatitis B Virus (HBV) Infection
Journal of Medical Virology
Tilføjet 4. januar 2026
15
Dynamics of Serum Hepatitis B Virus Nucleic Acids in Patients With Chronic Hepatitis B After Stopping Nucleos(t)ide Analogs Reveal Delayed Rebound of Hepatitis B Virus RNA
Journal of Medical Virology
Tilføjet 25. december 2025
16
Hepatitis B virus (HBV) revaccination in MSM and were born in the nationwide neonatal HBV vaccination era: A randomized clinical trial
International Journal of Infectious Diseases
Tilføjet 23. december 2025
17
Hepatitis B Virus Genomic Variability & HBV‐Related Disease Outcomes: A Molecular Epidemiology Perspective
Journal of Medical Virology
Tilføjet 24. december 2025
18
Coexistence of HBsAg and Anti‐HBs Predicts Severe Hepatic Fibrosis in Untreated Children With Hepatitis B Virus Infection
Journal of Medical Virology
Tilføjet 21. december 2025
19
Tattoo practices and risk of hepatitis B and hepatitis C infection in the French Constances study.
International Journal of Infectious Diseases
Tilføjet 10. december 2025
20
Glomerulonephritis, the Most Common Extrahepatic Manifestation Caused by Hepatitis B Virus Infection: Possible Pathogenesis and Therapeutic Approaches
Journal of Medical Virology
Tilføjet 7. december 2025